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Abstract
Background: Patient platforms are seen as promising technologies in an integrated care approach to involve cancer patients
in their own health care and to support them in managing their personal health information. However, few digital platforms
have been codesigned with patients and caregivers. Objective: To develop, implement, and evaluate the feasibility and
applicability of a digital oncology platform (DOP) for patients with cancer. Method: A mixed-method study was used,
employing a survey, interviews, and logged data from caregivers and patients. The DOP was designed in cooperation with
Information Technology (IT) staff, caregivers, and patients. Results: The DOP was actively used by half of the patients. These
active patients were positive about the DOP. Caregivers acknowledged the added value but also indicate that additional
workload was involved. Oncology nurse specialists are the users of the platform. General practitioners have indicated their
interest in the platform. Conclusion: Thanks to the codesign process, the DOP could be tailored to the expectations of the
end users. This study provides insight into which DOP functionalities the patients were interested in and includes further
recommendations for implementation.
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Introduction
The last decade has witnessed a rise in patient engagement
(1). Patients desire to be involved in their care process, as
they go online to self-diagnose symptoms, learn about their
condition and treatment options when the diagnosis is
known, and connect with people in similar situations to learn
from their experiences and share their own (2). In fact, there
has been a shift in the role of the patient from passive reci-
pient to active consumer (2). Since several studies have indi-
cated that patients who are actively involved exhibit better
health, have improved care experiences, and incur lower
health-care costs (3), patient engagement has rapidly become
a key component of many oncology programs (4). As such, a
variety of technologies have been developed to enhance
patient engagement and to support, among other things,
adherence to medication, behavioral changes, relationships,
and patient-reported outcomes (5). One technology that can
be used is a patient portal.
A patient portal is a secure web site for patients which
offers access to a variety of functions, including secure mes-
saging, protected health information (such as laboratory
results and medication lists), appointment scheduling, pro-
grams for self-monitoring, and patient questionnaires (6).
During cancer treatment, many patients welcome the oppor-
tunity to use engagement technologies, such as online tools
and mobile apps, to track their symptoms and possible side
effects (7). Patient platforms are thus seen as promising
technologies in an integrated care approach to involving
cancer patients in their own health care and in supporting
them in managing their personal health information (8).
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Beyond that, the information gathered in the patient portal can
be used by health care providers in clinical decision-making.
On the institutional level, there is a need to integrate patient-
related information, in order to permit information exchange
between the members of the multidisciplinary team and
between various institutions (such as between different hos-
pitals, or between a hospital and the primary care facility).
To date, the value of online interventions remains unclear
(5,9). In addition, there are very few digital platforms for can-
cer patients that have been developed through codesign with
patients and caregivers and that allow the integration of exist-
ing electronic care systems with 2-way communication with
patients and their caregivers, aswell as between caregivers (5).
This study aimed to develop, implement, and evaluate a digital
oncology platform (DOP) for patients with cancer.
Methods
In this article, we describe the development, implementation,
and the evaluation of the DOP. First, the platform was devel-
oped in a number of steps. Second, the DOP was implemen-
ted for patients with metastatic kidney cancer who were
receiving systemic treatment and for patients with a bone
tumor or sarcoma being treated at the Oncology Center,
Ghent University Hospital. Finally, the platform was evalu-
ated by describing how patients and caregivers used and
experienced it. We opted to integrate this oncological plat-
form into the Flanders Collaborative Care Platform Associ-
ation (CoZo; see Figure 1). The CoZo is part of Belgian
eHealth architecture and aims to share health data with the
aim of ensuring continuity of care. Over 40 Flemish hospi-
tals, 30 psychiatric institutions, and several rehabilitation
centers—as well as home nursing, extramural laboratories,
and radiology practices—are directly connected to CoZo.
Over 5000 physicians use CoZo each month, as it is con-
nected to their own patient files. This makes CoZo the larg-
est eHealth network in Belgium for the exchange of medical
data. The main advantage of integrating DOP with CoZo is
that it meets the high expectations for eHealth security and
provides real-time integration into the electronic patient file
at the hospital.
Development of the DOP
The literature was explored to determine the components
needed for the DOP and patients’ expectations of an
Figure 1. Start screen for patients after logging on to www.cozo.be (Flanders Collaborative Care Platform Association). The CoZo start
screen displayed for patients after logging with eID includes the following: the personal information of the patient, the hospitals where the
patient has a medical record, the patient’s therapeutic relationships, file logins, access to clinical results (such as X-ray images and laboratory
results), overview and scheduling of appointments at care facilities, proxy access (eg, for children), options and setting, and the “care
pathway” tile. From this page, the patient can click through to the different functions within the DOP. DOP indicates digital oncology
platform.
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oncology platform. The PubMed electronic database was
consulted with a combination of search terms, including
guidelines or directs and cancer or oncology and eHealth
or mHealth. Of 21 eligible articles, 7 relevant articles pro-
vided insight into the substantive and technical modalities of
eHealth systems (10-16). To enhance the chance of success-
ful implementation of the DOP, a “codesign” approach with
intramural caregivers, technology developers, and end users
was employed. This codesign process ensured that the exe-
cution of the project was optimally tailored to the needs of
the target group (17,18). The stakeholders who participated
in these meetings included physicians, nurses, nursing spe-
cialists, oncologists, head nurses, Information Technology
(IT) staff, a project coordinator, and project staff. Appendix
A shows the topics that were discussed at several monthly
group meetings, on the basis of which priorities were deter-
mined. The stakeholders who participated in these meetings
were physicians, nurses, nurse specialists, oncologists, head
nurses, IT staff, a project coordinator, and project staff.
The decisions thus made were converted by IT staff into a
prototype (see Figure 2) that was tested at different times by
both IT staff and potential end users (health-care providers).
Preliminary feedback on its layout, added value, and user-
friendliness was requested from patients, their family, and
health-care providers through individual interviews. Based
on their comments, amendments were made to the DOP.
Implementation of the DOP
In April 2015, a group of care providers involved in the care
of the patients (2 oncologists, 2 nursing consultants, 1 nur-
sing specialist, and 1 psychologist) were individually trained
in the use of DOP by an oncology nurse specialist, who was
also the project coordinator. In early May 2015, the DOP
was enrolled in 2 patient groups. IT support was available for
caregivers and patients (eg, to assist patients who had prob-
lems logging in to the platform). The patients’ general prac-
titioners (GPs) were mailed a manual describing the DOP,
with an additional statement that one of their patients was
participating in the study.
Evaluation of the DOP
Study design. A mixed-method triangulation design (19) that
combined qualitative and quantitative data obtained from
patients and their caregivers was used in order to obtain
different yet complementary data on the same topic.
Sample. Adult patients with metastatic renal cancer and
patients with a bone tumor or sarcoma were included.
Patients with any of the following criteria were excluded:
(1) not having a computer with an Internet connection, (2)
not being Belgian, (3) not Dutch-speaking, (4) suffering
from a cognitive or psychological disorder (as assessed by
the research team), and (5) unable to read or write (as judged
by the research team).
Procedure. The project evaluation proceeded from May 2015
to December 2015. The DOP was presented to those patients
who met the inclusion criteria by the physician or the nursing
specialist. The participants were asked to test the DOP for 3
months.
Data collection. After 3 months, semistructured interviews
were held with patients and their care providers to gain
deeper insight into the user-friendliness and applicability
of the DOP. Patients additionally received a validated survey
after 3 months using the DOP. This survey, based on the
questionnaire of Bakken et al, assessed the user-
friendliness of the DOP and users’ satisfaction with it (20).
The original scales were translated into Dutch using the
standard back-translation technique. A 14-item scale for
user-friendliness was used (a ¼ 0.809 in our study sample).
A sample user-friendliness question is: “I am more involved
in my care using the digital patient report.” We used 8 items
for the satisfaction scale (a ¼ 0.869 in the current sample).
One of the 8 questions for satisfaction is: “In general, I am
satisfied with the digital oncology platform.” The usability
of the 8 different sections of the system was also asked (see
Figures 1 and 2). Reponses were provided on a 5-point Likert
scale, with anchors ranging from 1 (strongly disagree) to 5
(strongly agree), and for usability from 1 (not at all useful) to
5 (very useful). Previous research provides evidence of the
high reliability and validity of evidence of perceptions of
eHealth (21).
Similarly, system-related log data were tracked—namely,
the number of logins to the system (by patients and care-
givers), the number of times the various sections were con-
sulted, the number of messages sent, and the number of
completed diary entries. Demographic and clinical variables
were also collected from patients.
Data analysis. Interviews were conducted with the end users
by telephone and face-to-face and were recorded on tape.
The findings were noted immediately after the interview,
and the interviews were transcribed verbatim. Qualitative
data were analyzed using thematic content analysis, which
was carried out by 2 researchers experienced in qualitative
research.
The sample and study variables underwent descriptive
statistical analysis. Cronbach alpha reliability scores were
calculated to test the internal consistency of the scales using
SPSS software (version 25; IBM, Chicago, Illinois).
Ethical considerations. The study protocol was approved by the
institutional review board (B670201524244), and all parti-
cipants took part voluntarily. Written informed consent was
obtained from all patients.
Results
A total of 29 patients were selected to evaluate the DOP.
Three did not meet the inclusion criteria and 3 refused to
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participate (participation was too cumbersome or they saw
no added value in the project). As such, 23 patients partici-
pated. Appendix B gives an overview of the demographic
variables of the participating patients.
Experience of Active and Nonactive Patients With DOP
Thirteen patients were not active (logging in once or not
at all) and 10 patients were active on DOP (logging in
more than once). Table 1 shows the consultation and
registration behavior of the active patients. The digital
platform was most often used to register clinical com-
plaints in the online diary.
The interviews demonstrated that the active patients were
mainly positive about the possibility of consulting their med-
ical results and recording their complaints. The latter tool
was especially valuable because patients then felt that they
had been “seen and heard” in the time between face-to-face
consultations. None of the patients consulted the question
prompt list. The information section was also rarely viewed.
They generally found the system user-friendly and clear. The
following elements for improvement were suggested by one
or more patients: making DOP available as an app, so that
logging in with the eID could be avoided when registering
complaints; being able to view complaints already regis-
tered; being able to consult a schematic overview (summary)
of the registered complaints in order to have a personal diary;
an integrated notebook in the DOP that could be used to pass
on matters that should have been discussed during the con-
sultation, such as requesting a prescription; and integrating
Figure 2. The digital oncology platform for patients, showing the individualized care path. The care path tile of the DOP contains a chart of
the individualized care path (different steps can be chosen for each patient, which makes the pathway customized), reliable information about
the cancer and its treatment, links to relevant web sites, contact details for the treatment team, secure conversations with the treatment
team, self-registration of complaints and other problems in a diary, and other questionnaires. In addition to the modalities identified in the
literature, the stakeholder group decided to integrate question prompt list. The nurse or doctor can individualize the care path for the
patient in a user-friendly way. The care path linked to a specific type of cancer or treatment has been preprogrammed into the DOP. The
health-care provider selects the respective care path and chooses the phases that apply to the patient. The patient can report his or her
complaints in the DOP during treatment. In addition to reporting complaints by selected fixed items, the patient can also describe the
complaints in text. DOP indicates digital oncology platform.
Table 1. Consultation and Registration Behavior of Patients
on DOP.
Mean (SD)a Median Rangeb
Number of times logged on DOP 11.92 (25.3) 1 0.0-90.0
Number of times consulted
Information 0.75 (1.4) 0.0 0.0-6.0
Diary/questionnaire 14.92 (43.7) 0.5 0.0-199.0
Conversation 4.33 (8.1) 0.0 0.0-26.0
Question prompt list 0.00 (0.0) 0.0 0.0-0.0
Number of messages sent 2.13 (4.4) 0.0 0.0-211.0
Number of diary entries 15.42 (45.5) 0.0 0.0-15.0
Abbreviations: DOP, digital oncology platform; SD, standard deviation.
aThe data were not normally distributed, but the mean and standard devia-
tion are included in the table to simplify interpretation.
bRange: minimum-maximum.
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entries from a private blog in the system, where things can be
shared with family and friends.
Some of the inactive patients indicated that they had
experienced difficulties logging on the CoZo platform and
then did not try again. Other patients indicated that they did
not feel the need for information. This had to do, among
other things, with patients’ coping mechanisms, experience,
or lack of time. Patients who only came to the hospital in the
follow-up phase after treatment to discuss checkup results
were more interested in the functions such as the ability to
consult appointments in the hospital and the results of the
medical examinations on CoZo. Two patients also indicated
that they had clinical complaints at the time of chemother-
apy, but due to fatigue, they did not register their symptoms
on the DOP platform.
The quantitative data on satisfaction, user-friendliness,
and usability for the patients are shown in Table 2. The
average score for satisfaction was 4.09 (minimum 3.1 and
maximum 4.8 on a scale of 1-5). The average score for user-
friendliness was 3.81 (minimum 3.3, maximum 4.4 on a
scale of 1-5). The usability of the individual tiles (see Fig-
ure 1) showed that the question prompt list tile had the
lowest score.
Experiences of Health-Care Providers in the Hospital
The consultation behavior (log data) of the care providers is
shown in Table 3. The oncology nurse specialists consulted
the DOP most frequently. The physicians and the psycholo-
gist consulted the DOP only to a limited extent.
Both physicians saw added value in providing reliable
information to patients, the ability of patients to register
illness complaints, and the ability to exchange research
results between care providers (eg, other hospitals and pri-
mary care). Both physicians indicated that medical results
should be released to patients with caution. Regarding the
registration of illness complaints and questions from
patients, the physicians indicated that they were informed
by the oncology nurse specialist if the illness complaints
required attention.
The specialist oncology nurses saw added value in the
DOP for both patients and health-care providers. They
had insight into (much of) the patient’s information
through DOP and patients could be better monitored. One
nurse indicated that working with DOP was additional to
standard care and thus increased the workload. The other
nurse had just started her consultations during the imple-
mentation of the DOP and it thus seemed to be more
obvious to her that DOP be presented to her patients. The
registration of illness complaints by patients was seen as
an added value, but also as an additional burden within
the limited hour available for the nursing consultation.
They felt that patients might expect a reaction from them
after sending a message or registering a complaint. Nev-
ertheless, during training on the DOP prior to its imple-
mentation, the nurses indicated that they still lacked
knowledge about the system. In particular, modifying the
individualized care path for the patients was difficult.
Nurses from the medical oncology department who mon-
itor patients during their chemotherapy indicated that it
helped them prepare for their telephone consultation with
the patient. In this way, specific questions could be asked
of the patient. The psychologist indicated that the system
had not yet been rolled out sufficiently for her use, as the
questions and patient registrations all seemed to be
addressed to physicians or nurses. She also indicated that
she would contact the patient by telephone more quickly,
because she could then receive nonverbal information (eg,
intonation). Care providers also mentioned additional
Table 2. Descriptive Statistics and Cronbach’s Alpha of the Mea-
sured Variables.
Variable
Mean
(SD)a Median Rangeb
Cronbach’s
a
User-friendliness 3.81 (0.8) 4.5 3.3-4.4 0.809
User satisfaction 4.09 (0.9) 4.0 3.1-4.8 0.869
Usability
Overall 4.28 (0.2) 4.4 4.0-4.5 0.831
Information and web
links
4.10 (0.7) 4.0 3.0-5.0
Diary 4.40 (0.7) 4.5 3.0-5.0
Questionnaire 4.00 (0.5) 4.0 3.0-5.0
Conversation 4.50 (0.5) 4.5 4.0-5.0
Question prompt list 3.80 (0.4) 4.0 3.0-4.0
Overview
appointments
4.50 (0.9) 5.0 2.0-5.0
Team contact 4.60 (0.5) 5.0 4.0-5.0
Results overview 4.30 (0.7) 4.0 3.0-5.0
Abbreviation: SD, standard deviation.
aThe data were not normally distributed, but the mean and standard devia-
tion are included in the table to simplify interpretation.
bRange: minimum-maximum.
Table 3. Consultation Behavior of Care Providers on DOP.
Mean (SD)a Median Rangea
Physician (n ¼ 2) 2.5 (0.71) 2.50 2-3
Nurse specialistb (n ¼ 1) 136 (-) - -
Nurse consultantc (n ¼ 2) 105.5 (44.55) 105.50 74-137
Nursed (n ¼ 9) 9.60 (4.51) 12.00 2-13
Psychologist (n ¼ 1) 1 (-) - -
Abbreviations: DOP, digital oncology platform; SD, standard deviation.
aRange: minimum-maximum.
bNurse with expertise in the professional field and the content and struc-
ture of the digital oncology platform.
cNurse responsible for the nursing consultation hour in which patients (and
relatives) receive support from an oncology specialist on their disease
process.
dNurse at the department of medical oncology who follows patients during
chemotherapy.
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functionalities that would improve the DOP: allowing
video conferencing (providing face-to-face contact
between patient and health-care provider at a distance),
providing signals when abnormal values are registered by
the patient, and offering (graphic) overviews when fol-
lowing parameters.
Consulting GPs. The majority of GPs (n ¼ 13) consulted the
CoZo digital platform regularly to access results of patients.
However, none of the GPs consulted the registrations of
patients in the DOP, but a majority (n ¼ 12) expressed inter-
est in being involved.
Discussion
The literature shows that patients desire online access to
their medical records and insight into the progress of their
health status (10-16). For example, patients are positive
about having online access to their laboratory results,
medication lists, and care process, as well as about send-
ing messages to health-care providers (13). Some existing
digital programs seem to be effective in these aspects
(12). The common modalities in these digital programs
include information about cancer, answers to frequently
asked questions, and the ability to monitor symptoms.
With regard to the technical modalities, attention should
be paid to the user-friendliness and simplicity of the sys-
tem, as well as its privacy, confidentiality, and compat-
ibility with other systems (14). As such, the DOP meets
all these basic user expectations, as was confirmed by our
results.
The codesign of the program was an important asset in
the development and further improvement of DOP.
Research shows that the development and successful imple-
mentation of applications for telemonitoring in health care
is difficult (22). One of the reasons for this is the lack of
needs-driven development that is tailored to the specific
needs of the sector and the target group. By means of code-
sign, where technology developers and health-care provi-
ders met, the DOP could be tailored to the end users.
Patients and their families are still actively involved in the
testing of new modules and applications in the DOP, and
their reflections are being taking into account in its further
development.
In this project, only 3 patients (<10%) did not desire to
participate in the study, as they thought the project was too
demanding or did not see the added value of this tool in
their care process. Clearly there was a high level of will-
ingness to participate. However, few patients consulted the
DOP. Rozmovits and Ziebland have indicated that informa-
tion needs differ and change over time for cancer patients
(23). Cook et al also revealed a number of facilitators and
barriers in adopting and using telehealth. For example, hav-
ing a positive attitude and a perceived need were factors
encouraging patients to adopt and engage with a service
(24). Using the DOP could thus be connected to the phase
and individual needs of the patient, which may explain why
the DOP was not always consulted. However, it is impor-
tant to provide the tool, as information-seeking behavior is
a strategy that many people use as a means of coping with
and reducing stress throughout their cancer experience
(25). Cook et al also demonstrated that reassurance from
the onset was paramount to continued engagement (24). As
such, the role of the caregiver is of utmost importance in
this process.
Several theories of technology acceptance suggest that
high perceived usefulness and greater ease of use positively
affect usage behavior (26,27). When technology is relevant
to the job, there will be more perceived usefulness, which
consequentially influences the intention to use the technol-
ogy (27). All caregivers saw the added value of the DOP.
However, the DOP needs some adjustments to improve
usability, and a change in behavior among caregivers will
be necessary to get the DOP established in practice and to
actively promote its use in patients. It could be interesting
to examine how the DOP can be integrated in the daily
work of the health-care professionals. Support from man-
agement is needed, as the fit between organization, tech-
nology, and the user affects the factors related to user
acceptance (28).
The DOP offers an opportunity for primary health work-
ers to become better informed about the oncological care
path that their patient follows in hospital. Hospitals play an
important role in transitional care interventions and in coor-
dinating chronic care with better outcomes for the patients,
by taking a leading role in integrated care programs (29). In
this way, the DOP optimized the exchange of data and the
continuity of care across hospital walls.
Limitations
Although the patients were involved in evaluating the DOP,
and although the tool was amended on the basis of their
comments, patients were not involved in the project from
the start. As such, we might have missed the perspectives
of this important stakeholder group regarding the modalities
needed in the DOP. Designing the DOP and including the
perspectives of patients might have led to yield a tool with
better uptake and overall utility.
This was a pilot study conducted in a single university
hospital and was not intended to draw any conclusions
about the effectiveness of the DOP, as the sample was too
small for this. Research that attends to the implementation
of the DOP in several hospitals would be necessary to ver-
ify the value added in terms of empowerment, patient par-
ticipation, and improvement in quality of life. After all,
being able to demonstrate that an eHealth application
makes a substantial contribution to the intended health-
care objectives is an important condition for its effective
implementation (30).
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Conclusions
A prototype of a patient platform was developed by means of
codesign with IT developers and caregivers. The DOP was
actively used by half of the patients—and particularly by
patients in the active treatment phase. For newly diagnosed
patients with cancer, the DOP seems to add important value and
can be an additional medium that guides patients through their
treatment process. The study provided insight into which DOP
functionalities interested the patients and includes patients’ rec-
ommendations for implementation. Caregivers acknowledged
the added value, but also indicated that an additional workload
was involved.Oncology nurse specialistswere themain users of
the platform, while GPs indicated their interest in the platform.
Additionalmodalitieswere requested by patients and caregivers
and are to be included in the next version of the DOP.
Appendix
Content and Technical Modalities of the Digital
Oncology Patient (DOP) Platform.
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Appendix A. Content and Technical Modalities of the Digital
Oncology Patient (DOP) Platform.
Content Modalities Technical Modalities
 Making reports, discharge
letters, and research results
available (with the possibility
of foreclosure of certain data
for the patient)
 Providing the individualized
care path with access to
information about diagnosis,
treatment, and aftercare for
the patients and other
extramural care providers
 Working out online diaries/
scales where patients can
register at home (including the
registration of side effects due
to treatment, psychosocial
complaints, practical
problems) adapted to the type
of cancer and treatment
 Generating overviews/
summaries of an evolution of
certain parameters over short/
long term
 Offering an overview of all
planned appointments in the
hospital in the future and from
the past
 Sending messages for
nonurgent questions
 Access rights for the various
care providers of the
multidisciplinary team
 System
performance
 Privacy and
confidentiality
 Maintenance of the
digital system
 Availability of
(medical) data
 Integration into the
electronic patient
file
 Design and layout of
the DOP
Appendix B. Demographics of the Patients.
All Patients,
N ¼ 23
Active
Patients,
n ¼ 10
Not Active
Patients,
n ¼ 13
Gender
Male/female 13/10 7/3 6/7
Mean age
(min-max; SD)
47.1 (19-74;
17.8)
44.3 (19-69;
16.5)
49.2 (20-74;
19.0)
Living status
Living alone 2 0 2
Cohabit 21 10 11
Education
High school 12 7 5
Further education 11 3 8
Type of cancer
Bone cancer 16 6 10
Kidney cancer 7 4 3
Metastases
No 10 5 8
Yes 13 5 5
Phase treatment
Chemotherapy 6 3 3
Purpose treatment 10 6 4
Follow-up 7 1 6
Time of diagnosis
<6 months 10 4 6
6 months to <1 year 2 1 1
1 year to <5 years 7 2 5
>5 years 4 3 1
Estimate knowledge of
PC/Internet
Very good 8 5 3
Good 8 3 5
Average 2 1 1
Low 5 1 4
Average spend hours
on PC/week (min-
max; SD)
15.7 (0-50;
13.9)
18.4 (0-50;
14.1)
13.6 (0-50;
14.0)
Abbreviation: SD, standard deviation; PC, computer.
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